BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 24930593)

  • 1. Current understanding of HIV-1 and T-cell adaptive immunity: progress to date.
    Mohan T; Bhatnagar S; Gupta DL; Rao DN
    Microb Pathog; 2014 Aug; 73():60-9. PubMed ID: 24930593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The enduring tale of T cells in HIV immunopathogenesis.
    Vajpayee M; Negi N; Kurapati S
    Indian J Med Res; 2013 Nov; 138(5):682-99. PubMed ID: 24434321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. mRNA-based dendritic cell vaccination induces potent antiviral T-cell responses in HIV-1-infected patients.
    Van Gulck E; Vlieghe E; Vekemans M; Van Tendeloo VF; Van De Velde A; Smits E; Anguille S; Cools N; Goossens H; Mertens L; De Haes W; Wong J; Florence E; Vanham G; Berneman ZN
    AIDS; 2012 Feb; 26(4):F1-12. PubMed ID: 22156965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV-1 and hijacking of the host immune system: the current scenario.
    Imran M; Manzoor S; Saalim M; Resham S; Ashraf J; Javed A; Waqar AB
    APMIS; 2016 Oct; 124(10):817-31. PubMed ID: 27539675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV/dendritic cell interaction: consequences in the pathogenesis of HIV infection.
    Barroca P; Calado M; Azevedo-Pereira JM
    AIDS Rev; 2014; 16(4):223-35. PubMed ID: 25350531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV-1, interferon and the interferon regulatory factor system: an interplay between induction, antiviral responses and viral evasion.
    Marsili G; Remoli AL; Sgarbanti M; Perrotti E; Fragale A; Battistini A
    Cytokine Growth Factor Rev; 2012; 23(4-5):255-70. PubMed ID: 22748237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune control of HIV-1 reservoirs.
    Autran B; Descours B; Bacchus C
    Curr Opin HIV AIDS; 2013 May; 8(3):204-10. PubMed ID: 23493099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Innate gamma/delta T-cells during HIV infection: Terra relatively Incognita in novel vaccination strategies?
    Agrati C; D'Offizi G; Gougeon ML; Malkovsky M; Sacchi A; Casetti R; Bordoni V; Cimini E; Martini F
    AIDS Rev; 2011; 13(1):3-12. PubMed ID: 21412385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV and interferon regulatory factor 1: a story of manipulation and control.
    Sivro A; Su RC; Plummer FA; Ball TB
    AIDS Res Hum Retroviruses; 2013 Nov; 29(11):1428-33. PubMed ID: 23984938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Innate immune sensing of HIV-1 infection.
    Jakobsen MR; Olagnier D; Hiscott J
    Curr Opin HIV AIDS; 2015 Mar; 10(2):96-102. PubMed ID: 25485569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cross-talk between virus and host innate immunity in pediatric HIV-1 infection and disease progression.
    Freguja R; Gianesin K; Zanchetta M; De Rossi A
    New Microbiol; 2012 Jul; 35(3):249-57. PubMed ID: 22842595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The emerging role of innate immunity in protection against HIV-1 infection.
    Lehner T; Wang Y; Pido-Lopez J; Whittall T; Bergmeier LA; Babaahmady K
    Vaccine; 2008 Jun; 26(24):2997-3001. PubMed ID: 18180080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natural killer cells in HIV-1 infection: a double-edged sword.
    Funke J; Dürr R; Dietrich U; Koch J
    AIDS Rev; 2011; 13(2):67-76. PubMed ID: 21587340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specific patterns of CD4-associated immunosenescence in vertically HIV-infected subjects.
    Méndez-Lagares G; Díaz L; Correa-Rocha R; León Leal JA; Ferrando-Martínez S; Ruiz-Mateos E; Pozo-Balado MM; Gurbindo MD; de José MI; Muñoz-Fernández MA; Leal M; Pacheco YM
    Clin Microbiol Infect; 2013 Jun; 19(6):558-65. PubMed ID: 22735071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV-1 Envelope Glycoprotein at the Interface of Host Restriction and Virus Evasion.
    Beitari S; Wang Y; Liu SL; Liang C
    Viruses; 2019 Mar; 11(4):. PubMed ID: 30935048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Innate immunity against HIV-1 infection.
    Altfeld M; Gale M
    Nat Immunol; 2015 Jun; 16(6):554-62. PubMed ID: 25988887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV-1 Tat addresses dendritic cells to induce a predominant Th1-type adaptive immune response that appears prevalent in the asymptomatic stage of infection.
    Fanales-Belasio E; Moretti S; Fiorelli V; Tripiciano A; Pavone Cossut MR; Scoglio A; Collacchi B; Nappi F; Macchia I; Bellino S; Francavilla V; Caputo A; Barillari G; Magnani M; Laguardia ME; Cafaro A; Titti F; Monini P; Ensoli F; Ensoli B
    J Immunol; 2009 Mar; 182(5):2888-97. PubMed ID: 19234184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. No differences in cellular immune responses between asymptomatic HIV type 1- and type 2-infected Gambian patients.
    Jaye A; Sarge-Njie R; Schim van der Loeff M; Todd J; Alabi A; Sabally S; Corrah T; Whittle H
    J Infect Dis; 2004 Feb; 189(3):498-505. PubMed ID: 14745708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of cytokines and chemokines in the regulation of innate immunity and HIV infection.
    Alfano M; Poli G
    Mol Immunol; 2005 Feb; 42(2):161-82. PubMed ID: 15488606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV-1 Nef impairs multiple T-cell functions in antigen-specific immune response in mice.
    Fujii H; Ato M; Takahashi Y; Otake K; Hashimoto S; Kaji T; Tsunetsugu-Yokota Y; Fujita M; Adachi A; Nakayama T; Taniguchi M; Koyasu S; Takemori T
    Int Immunol; 2011 Jul; 23(7):433-41. PubMed ID: 21642447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.